Absci Corporation, a data-first generative AI drug creation company, announced a strategic collaboration with AMD to deploy AMD Instinct™ accelerators and ROCm™ software to power...
Absci Corporation a data-first generative AI drug creation company, and Twist Bioscience Corporation a company enabling customers to succeed through its offering of high-quality synthetic...
Absci Corporation, a data-first generative AI drug creation company, announced the initiation of IND-enabling studies for ABS-101, a potential best-in-class anti-TL1A antibody designed using...
Absci, a generative AI drug creation company, and PrecisionLife®, a leading computational biology company driving precision medicine in complex chronic diseases, announced a collaboration...